Stada Arzneimittel AG’s private equity owners are pushing back a planned initial public offering of the German drugmaker ...

Private equity firm Hellman & Friedman has selected banks to lead the initial public offering of security group Verisure, ...

German pharma firm Stada plans to launch its initial public offering (IPO) as soon as Wednesday, two people familiar with the ...

Euronext NV Chief Executive Officer Stephane Boujnah said investors are increasingly moving money to Europe amid prospects ...

German generics and consumer healthcare major STADA Arzneimittel (SAZ: Xetra) today released financial results, which the ...

Comparative assessments and other editorial opinions are those of U.S. News and have not been previously reviewed, approved or endorsed by any other entities, such as banks, credit card issuers or ...

Only $2.5 billion has been raised through European initial public offerings so far this year, according to data compiled by ...

Issuers will hope the outperformance continues, as consensus is now that there will be no EPS growth in Q1. Bank of America ...

The boss of German healthcare company Stada says his business is a better bet than Big Pharma, as he tries to win over investors ahead of what could be Europe’s biggest IPO this year.

FRANKFURT (Reuters) -German pharma firm Stada plans to launch its initial public offering (IPO) as soon as Wednesday, two people familiar with the matter said, in a test for Europe's equity markets.